Jump to main content
Jump to site search

Issue 36, 2010
Previous Article Next Article

Potential photoactivated metallopharmaceuticals: from active molecules to supported drugs

Author affiliations

Abstract

Apart from cisplatin and some derivatives successful metallopharmaceuticals are still scarce in antitumour therapy. Although novel metal complexes have been investigated in preclinical settings several promising compounds failed in different phases. With the rise of new anticancer compounds new activation strategies have also evolved. Photochemical activation is one of the most important concepts as it uses pro-drugs whose activity can be triggered by light. This strategy offers the possibility to control the location, timing, and dosage of the therapeutic metal complex. Recent developments in the photoactivation of potential metallopharmaceuticals are summarized. Immobilisation of those drugs on solid matrices, such as films, particles, gels, and fibers, is an emerging field and recent findings are also discussed.

Graphical abstract: Potential photoactivated metallopharmaceuticals: from active molecules to supported drugs

Back to tab navigation

Publication details

The article was received on 14 Jun 2010, accepted on 14 Jul 2010 and first published on 18 Aug 2010


Article type: Feature Article
DOI: 10.1039/C0CC01887B
Citation: Chem. Commun., 2010,46, 6651-6662
  •   Request permissions

    Potential photoactivated metallopharmaceuticals: from active molecules to supported drugs

    D. Crespy, K. Landfester, U. S. Schubert and A. Schiller, Chem. Commun., 2010, 46, 6651
    DOI: 10.1039/C0CC01887B

Search articles by author

Spotlight

Advertisements